том 32 издание 2 страницы 577-583

Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder

Тип публикацииJournal Article
Дата публикации2017-01-07
scimago Q2
wos Q2
БС2
SJR0.941
CiteScore7.5
Impact factor3.5
ISSN08857490, 15737365
Biochemistry
Cellular and Molecular Neuroscience
Neurology (clinical)
Краткое описание
Hair cortisol is regarded as a promising marker of hypothalamic-pituitary-adrenal axis (HPAA) activity alterations due to stress, somatic and mental health conditions. Hair cortisol was previously reported to be elevated in patients with depression, however the data related to remission and recurrent depressive episodes are different. In this study, levels of hair cortisol were assessed in female patients with major depressive disorder (MDD) and the validity of hair cortisol as a marker of HPAA activity in this condition was evaluated. Hair cortisol was measured in 1 cm hair segments of 21 female patients with MDD and 22 female age-matched controls using enzyme-immunoassay analysis. Concurrently, serum cortisol was assessed and psychological status was evaluated using 17-item Hamilton Depression Rating Scale (HAMD-17), Beck Depression Inventory (BDI) and the Spielberger state trait anxiety inventory (STAI). The levels of hair cortisol were significantly lower in the MDD group, while serum cortisol levels were significantly higher in patients, as compared with controls. A significant negative correlation was found between HAMD-17 scores and hair cortisol. Decreased hair cortisol found in female patients with MDD as compared to controls suggests downregulation of HPAA activity during the preceding month. Further studies are needed to investigate the profiles of hair cortisol at different stages of depressive disorder to establish this parameter as a handy clinical tool.
Найдено 
Найдено 

Топ-30

Журналы

1
2
3
Journal of Psychiatric Research
3 публикации, 4.55%
Psychoneuroendocrinology
3 публикации, 4.55%
Neurochemical Journal
3 публикации, 4.55%
Neuropsychobiology
2 публикации, 3.03%
Frontiers in Psychiatry
2 публикации, 3.03%
Journal of Affective Disorders
2 публикации, 3.03%
Progress in Neuro-Psychopharmacology and Biological Psychiatry
2 публикации, 3.03%
Physiology and Behavior
2 публикации, 3.03%
Comprehensive Psychoneuroendocrinology
2 публикации, 3.03%
Biochemistry (Moscow)
2 публикации, 3.03%
Stress
2 публикации, 3.03%
Current Issues in Molecular Biology
1 публикация, 1.52%
BJPsych Open
1 публикация, 1.52%
Current Opinion in Psychiatry
1 публикация, 1.52%
Psychosomatic Medicine
1 публикация, 1.52%
Биохимия
1 публикация, 1.52%
Journal of International Medical Research
1 публикация, 1.52%
International Journal of Environmental Research and Public Health
1 публикация, 1.52%
Journal of Clinical Medicine
1 публикация, 1.52%
Neuroscience Bulletin
1 публикация, 1.52%
Cellular and Molecular Neurobiology
1 публикация, 1.52%
EPMA Journal
1 публикация, 1.52%
Scientific Reports
1 публикация, 1.52%
Neuroscience and Behavioral Physiology
1 публикация, 1.52%
AIDS and Behavior
1 публикация, 1.52%
Current obesity reports
1 публикация, 1.52%
Primates
1 публикация, 1.52%
Metabolic Brain Disease
1 публикация, 1.52%
Life Sciences
1 публикация, 1.52%
1
2
3

Издатели

2
4
6
8
10
12
14
16
18
Elsevier
18 публикаций, 27.27%
Springer Nature
10 публикаций, 15.15%
Pleiades Publishing
6 публикаций, 9.09%
Wiley
5 публикаций, 7.58%
MDPI
4 публикации, 6.06%
Taylor & Francis
4 публикации, 6.06%
S. Karger AG
3 публикации, 4.55%
Frontiers Media S.A.
3 публикации, 4.55%
Cambridge University Press
2 публикации, 3.03%
Ovid Technologies (Wolters Kluwer Health)
2 публикации, 3.03%
SAGE
1 публикация, 1.52%
Bentham Science Publishers Ltd.
1 публикация, 1.52%
BMJ
1 публикация, 1.52%
Walter de Gruyter
1 публикация, 1.52%
Media Sphere Publishing House
1 публикация, 1.52%
Cold Spring Harbor Laboratory
1 публикация, 1.52%
Agrarian Science
1 публикация, 1.52%
The Russian Academy of Sciences
1 публикация, 1.52%
2
4
6
8
10
12
14
16
18
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
66
Поделиться
Цитировать
ГОСТ |
Цитировать
Pochigaeva K. et al. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder // Metabolic Brain Disease. 2017. Vol. 32. No. 2. pp. 577-583.
ГОСТ со всеми авторами (до 50) Скопировать
Pochigaeva K., Druzhkova T., Yakovlev A., Onufriev M., Grishkina M., Chepelev A., Guekht A., Gulyaeva N. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder // Metabolic Brain Disease. 2017. Vol. 32. No. 2. pp. 577-583.
RIS |
Цитировать
TY - JOUR
DO - 10.1007/s11011-017-9952-0
UR - https://doi.org/10.1007/s11011-017-9952-0
TI - Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder
T2 - Metabolic Brain Disease
AU - Pochigaeva, Ksenia
AU - Druzhkova, Tatiana
AU - Yakovlev, Alexander
AU - Onufriev, Mikhail
AU - Grishkina, Maria
AU - Chepelev, Aleksey
AU - Guekht, Alla
AU - Gulyaeva, Natalia
PY - 2017
DA - 2017/01/07
PB - Springer Nature
SP - 577-583
IS - 2
VL - 32
PMID - 28064407
SN - 0885-7490
SN - 1573-7365
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2017_Pochigaeva,
author = {Ksenia Pochigaeva and Tatiana Druzhkova and Alexander Yakovlev and Mikhail Onufriev and Maria Grishkina and Aleksey Chepelev and Alla Guekht and Natalia Gulyaeva},
title = {Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder},
journal = {Metabolic Brain Disease},
year = {2017},
volume = {32},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1007/s11011-017-9952-0},
number = {2},
pages = {577--583},
doi = {10.1007/s11011-017-9952-0}
}
MLA
Цитировать
Pochigaeva, Ksenia, et al. “Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.” Metabolic Brain Disease, vol. 32, no. 2, Jan. 2017, pp. 577-583. https://doi.org/10.1007/s11011-017-9952-0.